These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23324098)

  • 1. Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia.
    Kalliomäki J; Annas P; Huizar K; Clarke C; Zettergren A; Karlsten R; Segerdahl M
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):212-8. PubMed ID: 23324098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of central nervous system-active doses of nabilone on capsaicin-induced pain and hyperalgesia.
    Kalliomäki J; Philipp A; Baxendale J; Annas P; Karlsten R; Segerdahl M
    Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):336-42. PubMed ID: 22233155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.
    Wang H; Bolognese J; Calder N; Baxendale J; Kehler A; Cummings C; Connell J; Herman G
    J Pain; 2008 Dec; 9(12):1088-95. PubMed ID: 19038771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal.
    Kalliomäki J; Segerdahl M; Webster L; Reimfelt A; Huizar K; Annas P; Karlsten R; Quiding H
    Scand J Pain; 2013 Jan; 4(1):17-22. PubMed ID: 29913883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin.
    Hohmann AG; Farthing JN; Zvonok AM; Makriyannis A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):446-53. PubMed ID: 14610224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model.
    Mathiesen O; Imbimbo BP; Hilsted KL; Fabbri L; Dahl JB
    J Pain; 2006 Aug; 7(8):565-74. PubMed ID: 16885013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
    Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
    Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic oral gabapentin on capsaicin-induced pain and hyperalgesia: a double-blind, placebo-controlled, crossover study.
    Wallace MS; Schulteis G
    Clin J Pain; 2008; 24(6):544-9. PubMed ID: 18574364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
    Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
    Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
    Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
    J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
    Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
    Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers.
    Schaffler K; Reitmeir P
    Arzneimittelforschung; 2004; 54(10):673-9. PubMed ID: 15553107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model.
    Wallace MS; Quessy S; Schulteis G
    Pharmacol Biochem Behav; 2004 Jun; 78(2):349-55. PubMed ID: 15219777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults.
    Wallace M; Duan R; Liu W; Locke C; Nothaft W
    Pain Med; 2016 Mar; 17(3):551-560. PubMed ID: 26814294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models--two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers.
    Gustorff B; Hauer D; Thaler J; Seis A; Draxler J
    Expert Opin Pharmacother; 2011 Dec; 12(18):2781-90. PubMed ID: 21774743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the effective dose of pregabalin on human experimental pain using the sequential up-down method.
    Wong W; Wallace MS
    J Pain; 2014 Jan; 15(1):25-31. PubMed ID: 24268111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
    Vincenzi F; Targa M; Corciulo C; Tabrizi MA; Merighi S; Gessi S; Saponaro G; Baraldi PG; Borea PA; Varani K
    Pain; 2013 Jun; 154(6):864-73. PubMed ID: 23518609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial.
    Lam VY; Wallace M; Schulteis G
    J Pain; 2011 Mar; 12(3):323-30. PubMed ID: 20889387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NGX426, an oral AMPA-kainate antagonist, is effective in human capsaicin-induced pain and hyperalgesia.
    Wallace MS; Lam V; Schettler J
    Pain Med; 2012 Dec; 13(12):1601-10. PubMed ID: 23110368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cannabinoid agonist CB-13 produces peripherally mediated analgesia in mice but elicits tolerance and signs of central nervous system activity with repeated dosing.
    Slivicki RA; Yi J; Brings VE; Huynh PN; Gereau RW
    Pain; 2022 Aug; 163(8):1603-1621. PubMed ID: 34961756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.